These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 16904985

  • 1. Mesenchymal stem cells enhance xenochimerism in NK-depleted hosts.
    Moadsiri A, Polchert D, Genrich K, Napoles P, Reina E, Turian J, Smith B, Bartholomew A.
    Surgery; 2006 Aug; 140(2):315-21. PubMed ID: 16904985
    [Abstract] [Full Text] [Related]

  • 2. Intra-bone marrow cotransplantation of donor mesenchymal stem cells in pig-to-NOD/SCID mouse bone marrow transplantation facilitates short-term xenogeneic hematopoietic engraftment.
    Eguchi H, Kuroiwa Y, Matsui A, Sada M, Nagaya N, Kawano S.
    Transplant Proc; 2008 Mar; 40(2):574-7. PubMed ID: 18374132
    [Abstract] [Full Text] [Related]

  • 3. Anti-mouse CD154 antibody treatment facilitates generation of mixed xenogeneic rat hematopoietic chimerism, prevents wasting disease and prolongs xenograft survival in mice.
    Masaki H, Appel MC, Leahy L, Leif J, Paquin L, Shultz LD, Mordes JP, Greiner DL, Rossini AA.
    Xenotransplantation; 2006 May; 13(3):224-32. PubMed ID: 16756565
    [Abstract] [Full Text] [Related]

  • 4. Co-infusion of donor bone marrow with host mesenchymal stem cells treats GVHD and promotes vascularized skin allograft survival in rats.
    Aksu AE, Horibe E, Sacks J, Ikeguchi R, Breitinger J, Scozio M, Unadkat J, Feili-Hariri M.
    Clin Immunol; 2008 Jun; 127(3):348-58. PubMed ID: 18387852
    [Abstract] [Full Text] [Related]

  • 5. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S.
    Blood Cells Mol Dis; 2008 Jun; 40(1):48-54. PubMed ID: 17827036
    [Abstract] [Full Text] [Related]

  • 6. Mesenchymal stem cells remain host-derived independent of the source of the stem-cell graft and conditioning regimen used.
    Bartsch K, Al-Ali H, Reinhardt A, Franke C, Hudecek M, Kamprad M, Tschiedel S, Cross M, Niederwieser D, Gentilini C.
    Transplantation; 2009 Jan 27; 87(2):217-21. PubMed ID: 19155975
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term survival of xenogeneic heart grafts achieved by costimulatory blockade and transient mixed chimerism.
    Murakami M, Ito H, Harada E, Enoki T, Sykes M, Hamano K.
    Transplantation; 2006 Jul 27; 82(2):275-81. PubMed ID: 16858292
    [Abstract] [Full Text] [Related]

  • 9. Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults.
    Gonzalo-Daganzo R, Regidor C, Martín-Donaire T, Rico MA, Bautista G, Krsnik I, Forés R, Ojeda E, Sanjuán I, García-Marco JA, Navarro B, Gil S, Sánchez R, Panadero N, Gutiérrez Y, García-Berciano M, Pérez N, Millán I, Cabrera R, Fernández MN.
    Cytotherapy; 2009 Jul 27; 11(3):278-88. PubMed ID: 19308773
    [Abstract] [Full Text] [Related]

  • 10. Donor-derived plasma transferrin facilitates the engraftment of xenogeneic (rat) bone marrow in irradiated mice.
    Pierpaoli W, Lesnikov V, Lesnikova M, Arrighi S.
    Bone Marrow Transplant; 1996 Jul 27; 18(1):203-7. PubMed ID: 8832016
    [Abstract] [Full Text] [Related]

  • 11. Anti-CD40L monoclonal antibodies can replace anti-CD4 monoclonal antibodies for the nonmyeloablative induction of mixed xenogeneic chimerism.
    Ito H, Takeuchi Y, Shaffer J, Sykes M.
    Transplantation; 2006 Jul 27; 82(2):251-7. PubMed ID: 16858289
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice.
    Niemeyer P, Vohrer J, Schmal H, Kasten P, Fellenberg J, Suedkamp NP, Mehlhorn AT.
    Cytotherapy; 2008 Jul 27; 10(8):784-95. PubMed ID: 18951271
    [Abstract] [Full Text] [Related]

  • 14. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM, Omdal BK, Dai KZ, Martens A, Benestad HB, Vaage JT, Rolstad B.
    Transplantation; 2008 Jan 15; 85(1):102-11. PubMed ID: 18192919
    [Abstract] [Full Text] [Related]

  • 15. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation.
    Villaron EM, Almeida J, López-Holgado N, Alcoceba M, Sánchez-Abarca LI, Sanchez-Guijo FM, Alberca M, Pérez-Simon JA, San Miguel JF, Del Cañizo MC.
    Haematologica; 2004 Dec 15; 89(12):1421-7. PubMed ID: 15590390
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Survival of bone marrow-derived mesenchymal stem cells in a xenotransplantation model.
    Wang Y, Chen X, Armstrong MA, Li G.
    J Orthop Res; 2007 Jul 15; 25(7):926-32. PubMed ID: 17415789
    [Abstract] [Full Text] [Related]

  • 18. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP, Li Z, Nador RG, Strober S.
    Transplantation; 2008 Feb 27; 85(4):607-14. PubMed ID: 18347541
    [Abstract] [Full Text] [Related]

  • 19. Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model.
    Sbano P, Cuccia A, Mazzanti B, Urbani S, Giusti B, Lapini I, Rossi L, Abbate R, Marseglia G, Nannetti G, Torricelli F, Miracco C, Bosi A, Fimiani M, Saccardi R.
    Arch Dermatol Res; 2008 Mar 27; 300(3):115-24. PubMed ID: 18259766
    [Abstract] [Full Text] [Related]

  • 20. Both gamma delta T cells and NK cells inhibit the engraftment of xenogeneic rat bone marrow cells and the induction of xenograft tolerance in mice.
    Nikolic B, Cooke DT, Zhao G, Sykes M.
    J Immunol; 2001 Jan 15; 166(2):1398-404. PubMed ID: 11145725
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.